Predictive value of pretreatment PD-L1 expression in EGFR-mutant non-small cell lung cancer: a meta-analysis

OBJECTIVE: To investigate the predictive value of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC) patients treated with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). METHODS: We conducted a systemic search of PubMed, EMBASE, and the Cochr...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Zhiyu, Lin, Huahang, Zhou, Ke, Deng, Senyi, Mei, Jiandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106834/
https://www.ncbi.nlm.nih.gov/pubmed/33964931
http://dx.doi.org/10.1186/s12957-021-02254-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106834/
https://www.ncbi.nlm.nih.gov/pubmed/33964931
http://dx.doi.org/10.1186/s12957-021-02254-x

Ejemplares similares